Massachusetts General Brigham (MGB) investigators, in a 403 patient clinical trial, discovered that 55% of those who received ketamine treatment experienced.
Of those who have been sick with the coronavirus, an estimated 15 percent developed prolonged symptoms linked to long COVID, often disrupting their lives and perplexing health care providers.
A new study finds ketamine as effective as electroconvulsive therapy (without its major side effects) for the treatment of nonpsychotic, treatment-resistant depression.
Imaging Informaticists from around the country will be gathering in Austin, TX from June 14-16 for the Annual Meeting of the Society for Imaging Informatics in Medicine (SIMM23). Imaging Technology News has compiled a summary of key program highlights of leading industry experts, educational sessions on hot topics, practitioners at all career levels and specialties, product vendors and special events to be presented by SIIM at the Austin Convention Center.